ARCHIVES

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

This article is from The Cancer Letter archive.

Vol. 36 No. 08 | March 5, 2010

Download PDF Visit The Full Archive

Related Articles

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

Obituaries: Paul Carbone; John Eisenberg; Paul Grotzinger

March 15, 2002

NCI Encourages IP Chemo For Stage III Ovarian Cancer

January 27, 2006

In Setback For Generics, Court Overturns FDA.

November 9, 2001

NCI Advisors Approve Expansion Of CCOPs, Minority-Based CCOPs; Approve Reissuance Of BMT Network RFA, RFPs For Preclinical Drug Studies

November 13, 2009

NCI To Pilot Text Chat On CancerNet And CIS Sites.

September 29, 2000